Skip to main content
. 2018 Oct 9;4(2):231–244. doi: 10.1016/j.ekir.2018.10.002

Table 2.

Meta-analysis of clinical characteristics and outcomes of patients with calciphylaxis according to treatment modality (derived from case series)

Variables Sodium thiosulfate
Surgical Parathyroidectomy
Cinacalcet
Hyperbaric oxygen therapy
Bisphosphonates
No. of studies No. of patients Weighted mean (95% CI) No. of studies No. of patients Weighted mean (95% CI) No. of studies No. of patients Weighted mean (95% CI) No. of studies No. of patients Weighted mean (95% CI) No. of studies No. of patients Weighted mean (95% CI)
Clinical characteristics
Age, yr 14 321 58.5 (44.0–73.0) 11 54 53.3 (48.1–58.4) 3 12 53.3 (36.3–70.2) 5 61 57.7 (54.0–61.4) 1 3 58.5 (44.0–73.0)
Dialysis vintage, yr 8 228 2.9 (2.1–3.7) 7 33 7.3 (5.1–9.4) 2 10 3.5 (1.6–5.5) 3 18 8.4 (1.5–18.3)
Serum calcium, mg/dl 9 303 9.2 (8.8–9.7) 10 51 9.5 (9.0,10.0) 3 12 8.8 (6.5,11.1) 5 61 9.4 (8.7–10.0) 1 3 9.0 (7.9–10.3)
Serum phosphorus, mg/dl 9 303 5.7 (5.4–6.1) 10 51 5.7 (5.4–6.1) 3 12 5.3 (4.7–5.9) 5 61 6.6 (5.4–7.8) 1 3 6.3 (3.9–8.7)
Serum albumin, g/dl 4 269 3.0 (2.6–3.5) 2 12 3.4 (2.9–3.9) 1 2 3.5 (3.5–3.5) 2 14 2.8 (2.2–3.3) 1 3 3.1 (2.2–4.0)
Serum intact parathyroid hormone, pg/ml 10 305 431.3 (329.0–533.5) 8 38 640.1 (393.3–886.8) 3 12 999.6 (683.4–1315.7) 4 50 202.4 (55.1–349.8) 1 3 459.0 (97.7–1015.7)
Clinical outcomes
Amputation, % 12 85 11.9 (6.5–20.9) 10 44 41.1(24.3–60.2) 3 12 10.4 (2.1–38.8) 4 52 9.3 (3.0–25.6)
Worsening of lesions, % 14 321 30.4 (24.3–37.3) 11 54 43.7 (24.4–65.1) 3 12 30.4 (4.9–78.9) 4 52 37.3 (25.3–51.2) 1 3 66.7 (15.4–95.7)
Mortality, % 14 321 44.4 (31.1–58.6) 10 44 44.9 (29.2–61.7) 3 12 62.8(8.2–97.0) 4 52 43.8 (11.3–82.6)